BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10026267)

  • 1. Glycosylation is important for binding to human calcitonin receptors.
    Ho HH; Gilbert MT; Nussenzveig DR; Gershengorn MC
    Biochemistry; 1999 Feb; 38(6):1866-72. PubMed ID: 10026267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodocalcitonin binds to human calcitonin receptors with higher affinity than calcitonin.
    Cohen DP; Nussenzveig DR; Gershengorn MC
    Endocrinology; 1996 Oct; 137(10):4507-10. PubMed ID: 8828514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor.
    Bailey RJ; Hay DL
    Br J Pharmacol; 2007 Jul; 151(5):678-87. PubMed ID: 17486143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of the calcitonin receptor-like receptor at Asn(60) or Asn(112) is important for cell surface expression.
    Bühlmann N; Aldecoa A; Leuthäuser K; Gujer R; Muff R; Fischer JA; Born W
    FEBS Lett; 2000 Dec; 486(3):320-4. PubMed ID: 11119727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function.
    Gujer R; Aldecoa A; Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Biochemistry; 2001 May; 40(18):5392-8. PubMed ID: 11331002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function.
    Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA
    Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-glycosylation in the expression and functional properties of human AT1 receptor.
    Lanctôt PM; Leclerc PC; Escher E; Leduc R; Guillemette G
    Biochemistry; 1999 Jul; 38(27):8621-7. PubMed ID: 10393537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
    Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.
    Flahaut M; Pfister C; Rossier BC; Firsov D
    Biochemistry; 2003 Sep; 42(34):10333-41. PubMed ID: 12939163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor.
    Conner AC; Simms J; Conner MT; Wootten DL; Wheatley M; Poyner DR
    Biochemistry; 2006 Oct; 45(43):12976-85. PubMed ID: 17059214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the sites of asparagine-linked glycosylation on the human thyrotropin receptor and studies on their role in receptor function and expression.
    Nagayama Y; Nishihara E; Namba H; Yamashita S; Niwa M
    J Pharmacol Exp Ther; 2000 Oct; 295(1):404-9. PubMed ID: 10992007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
    Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
    J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor.
    Ma JN; Currier EA; Essex A; Feddock M; Spalding TA; Nash NR; Brann MR; Burstein ES
    Biochem Pharmacol; 2004 Apr; 67(7):1279-84. PubMed ID: 15013843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin.
    Wu SV; Yang M; Avedian D; Birnbaumer M; Walsh JH
    Mol Pharmacol; 1999 May; 55(5):795-803. PubMed ID: 10220557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells.
    Quirk PL; Rao S; Roth BL; Siegel RE
    J Neurosci Res; 2004 Aug; 77(4):498-506. PubMed ID: 15264219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.